Organization Profile

You just read:

OncoGenex Announces Plans for the Initiation of the Rainier™ Clinical Trial Evaluating OGX-427 in Combination with ABRAXANE® plus Gemcitabine in Patients with Metastatic Pancreatic Cancer

News provided by

OncoGenex Pharmaceuticals, Inc.

May 01, 2013, 06:30 ET